nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemifloxacin—Haematuria—Methotrexate—urinary bladder cancer	0.000971	0.000971	CcSEcCtD
Gemifloxacin—Pancreatitis—Doxorubicin—urinary bladder cancer	0.000969	0.000969	CcSEcCtD
Gemifloxacin—Dyspnoea—Etoposide—urinary bladder cancer	0.000966	0.000966	CcSEcCtD
Gemifloxacin—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.000964	0.000964	CcSEcCtD
Gemifloxacin—Somnolence—Etoposide—urinary bladder cancer	0.000964	0.000964	CcSEcCtD
Gemifloxacin—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000963	0.000963	CcSEcCtD
Gemifloxacin—Vomiting—Thiotepa—urinary bladder cancer	0.00096	0.00096	CcSEcCtD
Gemifloxacin—Pneumonia—Epirubicin—urinary bladder cancer	0.000958	0.000958	CcSEcCtD
Gemifloxacin—Infestation NOS—Epirubicin—urinary bladder cancer	0.000953	0.000953	CcSEcCtD
Gemifloxacin—Infestation—Epirubicin—urinary bladder cancer	0.000953	0.000953	CcSEcCtD
Gemifloxacin—Rash—Thiotepa—urinary bladder cancer	0.000952	0.000952	CcSEcCtD
Gemifloxacin—Dermatitis—Thiotepa—urinary bladder cancer	0.000951	0.000951	CcSEcCtD
Gemifloxacin—Agranulocytosis—Methotrexate—urinary bladder cancer	0.00095	0.00095	CcSEcCtD
Gemifloxacin—Headache—Thiotepa—urinary bladder cancer	0.000945	0.000945	CcSEcCtD
Gemifloxacin—Decreased appetite—Etoposide—urinary bladder cancer	0.000942	0.000942	CcSEcCtD
Gemifloxacin—Renal failure—Epirubicin—urinary bladder cancer	0.000937	0.000937	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000936	0.000936	CcSEcCtD
Gemifloxacin—Body temperature increased—Cisplatin—urinary bladder cancer	0.000935	0.000935	CcSEcCtD
Gemifloxacin—Fatigue—Etoposide—urinary bladder cancer	0.000935	0.000935	CcSEcCtD
Gemifloxacin—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000934	0.000934	CcSEcCtD
Gemifloxacin—Stomatitis—Epirubicin—urinary bladder cancer	0.000929	0.000929	CcSEcCtD
Gemifloxacin—Pain—Etoposide—urinary bladder cancer	0.000927	0.000927	CcSEcCtD
Gemifloxacin—Constipation—Etoposide—urinary bladder cancer	0.000927	0.000927	CcSEcCtD
Gemifloxacin—Haemoglobin—Methotrexate—urinary bladder cancer	0.000919	0.000919	CcSEcCtD
Gemifloxacin—Haemorrhage—Methotrexate—urinary bladder cancer	0.000914	0.000914	CcSEcCtD
Gemifloxacin—Asthenia—Gemcitabine—urinary bladder cancer	0.000911	0.000911	CcSEcCtD
Gemifloxacin—Haematuria—Epirubicin—urinary bladder cancer	0.000908	0.000908	CcSEcCtD
Gemifloxacin—Pharyngitis—Methotrexate—urinary bladder cancer	0.000907	0.000907	CcSEcCtD
Gemifloxacin—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000903	0.000903	CcSEcCtD
Gemifloxacin—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000903	0.000903	CcSEcCtD
Gemifloxacin—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000901	0.000901	CcSEcCtD
Gemifloxacin—Pruritus—Gemcitabine—urinary bladder cancer	0.000898	0.000898	CcSEcCtD
Gemifloxacin—Nausea—Thiotepa—urinary bladder cancer	0.000896	0.000896	CcSEcCtD
Gemifloxacin—Urethral disorder—Methotrexate—urinary bladder cancer	0.000896	0.000896	CcSEcCtD
Gemifloxacin—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000892	0.000892	CcSEcCtD
Gemifloxacin—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000889	0.000889	CcSEcCtD
Gemifloxacin—Pneumonia—Doxorubicin—urinary bladder cancer	0.000887	0.000887	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000886	0.000886	CcSEcCtD
Gemifloxacin—Pruritus—Fluorouracil—urinary bladder cancer	0.000883	0.000883	CcSEcCtD
Gemifloxacin—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000882	0.000882	CcSEcCtD
Gemifloxacin—Infestation—Doxorubicin—urinary bladder cancer	0.000882	0.000882	CcSEcCtD
Gemifloxacin—Visual impairment—Methotrexate—urinary bladder cancer	0.000881	0.000881	CcSEcCtD
Gemifloxacin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000869	0.000869	CcSEcCtD
Gemifloxacin—Renal failure—Doxorubicin—urinary bladder cancer	0.000867	0.000867	CcSEcCtD
Gemifloxacin—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000864	0.000864	CcSEcCtD
Gemifloxacin—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000864	0.000864	CcSEcCtD
Gemifloxacin—Urticaria—Etoposide—urinary bladder cancer	0.000861	0.000861	CcSEcCtD
Gemifloxacin—Haemoglobin—Epirubicin—urinary bladder cancer	0.00086	0.00086	CcSEcCtD
Gemifloxacin—Stomatitis—Doxorubicin—urinary bladder cancer	0.000859	0.000859	CcSEcCtD
Gemifloxacin—Abdominal pain—Etoposide—urinary bladder cancer	0.000857	0.000857	CcSEcCtD
Gemifloxacin—Body temperature increased—Etoposide—urinary bladder cancer	0.000857	0.000857	CcSEcCtD
Gemifloxacin—Haemorrhage—Epirubicin—urinary bladder cancer	0.000855	0.000855	CcSEcCtD
Gemifloxacin—Eye disorder—Methotrexate—urinary bladder cancer	0.000854	0.000854	CcSEcCtD
Gemifloxacin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000854	0.000854	CcSEcCtD
Gemifloxacin—Asthenia—Cisplatin—urinary bladder cancer	0.000849	0.000849	CcSEcCtD
Gemifloxacin—Pharyngitis—Epirubicin—urinary bladder cancer	0.000849	0.000849	CcSEcCtD
Gemifloxacin—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000848	0.000848	CcSEcCtD
Gemifloxacin—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000845	0.000845	CcSEcCtD
Gemifloxacin—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000843	0.000843	CcSEcCtD
Gemifloxacin—Haematuria—Doxorubicin—urinary bladder cancer	0.000841	0.000841	CcSEcCtD
Gemifloxacin—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000841	0.000841	CcSEcCtD
Gemifloxacin—Urethral disorder—Epirubicin—urinary bladder cancer	0.000838	0.000838	CcSEcCtD
Gemifloxacin—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000834	0.000834	CcSEcCtD
Gemifloxacin—Angiopathy—Methotrexate—urinary bladder cancer	0.000829	0.000829	CcSEcCtD
Gemifloxacin—Immune system disorder—Methotrexate—urinary bladder cancer	0.000826	0.000826	CcSEcCtD
Gemifloxacin—Dizziness—Fluorouracil—urinary bladder cancer	0.000825	0.000825	CcSEcCtD
Gemifloxacin—Visual impairment—Epirubicin—urinary bladder cancer	0.000824	0.000824	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000824	0.000824	CcSEcCtD
Gemifloxacin—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000823	0.000823	CcSEcCtD
Gemifloxacin—Diarrhoea—Cisplatin—urinary bladder cancer	0.00081	0.00081	CcSEcCtD
Gemifloxacin—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000809	0.000809	CcSEcCtD
Gemifloxacin—Vomiting—Gemcitabine—urinary bladder cancer	0.000807	0.000807	CcSEcCtD
Gemifloxacin—Mental disorder—Methotrexate—urinary bladder cancer	0.000801	0.000801	CcSEcCtD
Gemifloxacin—Rash—Gemcitabine—urinary bladder cancer	0.0008	0.0008	CcSEcCtD
Gemifloxacin—Dermatitis—Gemcitabine—urinary bladder cancer	0.0008	0.0008	CcSEcCtD
Gemifloxacin—Eye disorder—Epirubicin—urinary bladder cancer	0.000799	0.000799	CcSEcCtD
Gemifloxacin—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000795	0.000795	CcSEcCtD
Gemifloxacin—Headache—Gemcitabine—urinary bladder cancer	0.000795	0.000795	CcSEcCtD
Gemifloxacin—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000794	0.000794	CcSEcCtD
Gemifloxacin—Flushing—Epirubicin—urinary bladder cancer	0.000794	0.000794	CcSEcCtD
Gemifloxacin—Vomiting—Fluorouracil—urinary bladder cancer	0.000794	0.000794	CcSEcCtD
Gemifloxacin—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000791	0.000791	CcSEcCtD
Gemifloxacin—Rash—Fluorouracil—urinary bladder cancer	0.000787	0.000787	CcSEcCtD
Gemifloxacin—Dermatitis—Fluorouracil—urinary bladder cancer	0.000786	0.000786	CcSEcCtD
Gemifloxacin—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000785	0.000785	CcSEcCtD
Gemifloxacin—Headache—Fluorouracil—urinary bladder cancer	0.000782	0.000782	CcSEcCtD
Gemifloxacin—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000782	0.000782	CcSEcCtD
Gemifloxacin—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.00078	0.00078	CcSEcCtD
Gemifloxacin—Dysgeusia—Methotrexate—urinary bladder cancer	0.000779	0.000779	CcSEcCtD
Gemifloxacin—Asthenia—Etoposide—urinary bladder cancer	0.000778	0.000778	CcSEcCtD
Gemifloxacin—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000778	0.000778	CcSEcCtD
Gemifloxacin—Angiopathy—Epirubicin—urinary bladder cancer	0.000776	0.000776	CcSEcCtD
Gemifloxacin—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000776	0.000776	CcSEcCtD
Gemifloxacin—Immune system disorder—Epirubicin—urinary bladder cancer	0.000773	0.000773	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000771	0.000771	CcSEcCtD
Gemifloxacin—Back pain—Methotrexate—urinary bladder cancer	0.00077	0.00077	CcSEcCtD
Gemifloxacin—Pruritus—Etoposide—urinary bladder cancer	0.000767	0.000767	CcSEcCtD
Gemifloxacin—Visual impairment—Doxorubicin—urinary bladder cancer	0.000763	0.000763	CcSEcCtD
Gemifloxacin—Nausea—Gemcitabine—urinary bladder cancer	0.000754	0.000754	CcSEcCtD
Gemifloxacin—Vomiting—Cisplatin—urinary bladder cancer	0.000752	0.000752	CcSEcCtD
Gemifloxacin—Mental disorder—Epirubicin—urinary bladder cancer	0.000749	0.000749	CcSEcCtD
Gemifloxacin—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000748	0.000748	CcSEcCtD
Gemifloxacin—Rash—Cisplatin—urinary bladder cancer	0.000746	0.000746	CcSEcCtD
Gemifloxacin—Dermatitis—Cisplatin—urinary bladder cancer	0.000745	0.000745	CcSEcCtD
Gemifloxacin—Diarrhoea—Etoposide—urinary bladder cancer	0.000742	0.000742	CcSEcCtD
Gemifloxacin—Nausea—Fluorouracil—urinary bladder cancer	0.000741	0.000741	CcSEcCtD
Gemifloxacin—Eye disorder—Doxorubicin—urinary bladder cancer	0.00074	0.00074	CcSEcCtD
Gemifloxacin—Anaemia—Methotrexate—urinary bladder cancer	0.000735	0.000735	CcSEcCtD
Gemifloxacin—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000735	0.000735	CcSEcCtD
Gemifloxacin—Flushing—Doxorubicin—urinary bladder cancer	0.000735	0.000735	CcSEcCtD
Gemifloxacin—Flatulence—Epirubicin—urinary bladder cancer	0.000734	0.000734	CcSEcCtD
Gemifloxacin—Tension—Epirubicin—urinary bladder cancer	0.000731	0.000731	CcSEcCtD
Gemifloxacin—Dysgeusia—Epirubicin—urinary bladder cancer	0.000729	0.000729	CcSEcCtD
Gemifloxacin—Nervousness—Epirubicin—urinary bladder cancer	0.000723	0.000723	CcSEcCtD
Gemifloxacin—Back pain—Epirubicin—urinary bladder cancer	0.00072	0.00072	CcSEcCtD
Gemifloxacin—Angiopathy—Doxorubicin—urinary bladder cancer	0.000718	0.000718	CcSEcCtD
Gemifloxacin—Dizziness—Etoposide—urinary bladder cancer	0.000717	0.000717	CcSEcCtD
Gemifloxacin—Muscle spasms—Epirubicin—urinary bladder cancer	0.000716	0.000716	CcSEcCtD
Gemifloxacin—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000715	0.000715	CcSEcCtD
Gemifloxacin—Vertigo—Methotrexate—urinary bladder cancer	0.000715	0.000715	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000713	0.000713	CcSEcCtD
Gemifloxacin—Leukopenia—Methotrexate—urinary bladder cancer	0.000712	0.000712	CcSEcCtD
Gemifloxacin—Nausea—Cisplatin—urinary bladder cancer	0.000703	0.000703	CcSEcCtD
Gemifloxacin—Mental disorder—Doxorubicin—urinary bladder cancer	0.000693	0.000693	CcSEcCtD
Gemifloxacin—Vomiting—Etoposide—urinary bladder cancer	0.000689	0.000689	CcSEcCtD
Gemifloxacin—Anaemia—Epirubicin—urinary bladder cancer	0.000688	0.000688	CcSEcCtD
Gemifloxacin—Rash—Etoposide—urinary bladder cancer	0.000684	0.000684	CcSEcCtD
Gemifloxacin—Dermatitis—Etoposide—urinary bladder cancer	0.000683	0.000683	CcSEcCtD
Gemifloxacin—Headache—Etoposide—urinary bladder cancer	0.000679	0.000679	CcSEcCtD
Gemifloxacin—Flatulence—Doxorubicin—urinary bladder cancer	0.000679	0.000679	CcSEcCtD
Gemifloxacin—Arthralgia—Methotrexate—urinary bladder cancer	0.000677	0.000677	CcSEcCtD
Gemifloxacin—Myalgia—Methotrexate—urinary bladder cancer	0.000677	0.000677	CcSEcCtD
Gemifloxacin—Tension—Doxorubicin—urinary bladder cancer	0.000676	0.000676	CcSEcCtD
Gemifloxacin—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000675	0.000675	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000673	0.000673	CcSEcCtD
Gemifloxacin—Nervousness—Doxorubicin—urinary bladder cancer	0.000669	0.000669	CcSEcCtD
Gemifloxacin—Vertigo—Epirubicin—urinary bladder cancer	0.000669	0.000669	CcSEcCtD
Gemifloxacin—Syncope—Epirubicin—urinary bladder cancer	0.000668	0.000668	CcSEcCtD
Gemifloxacin—Leukopenia—Epirubicin—urinary bladder cancer	0.000666	0.000666	CcSEcCtD
Gemifloxacin—Back pain—Doxorubicin—urinary bladder cancer	0.000666	0.000666	CcSEcCtD
Gemifloxacin—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000662	0.000662	CcSEcCtD
Gemifloxacin—Palpitations—Epirubicin—urinary bladder cancer	0.000658	0.000658	CcSEcCtD
Gemifloxacin—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000654	0.000654	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000649	0.000649	CcSEcCtD
Gemifloxacin—Nausea—Etoposide—urinary bladder cancer	0.000644	0.000644	CcSEcCtD
Gemifloxacin—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000637	0.000637	CcSEcCtD
Gemifloxacin—Anaemia—Doxorubicin—urinary bladder cancer	0.000637	0.000637	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000636	0.000636	CcSEcCtD
Gemifloxacin—Myalgia—Epirubicin—urinary bladder cancer	0.000634	0.000634	CcSEcCtD
Gemifloxacin—Arthralgia—Epirubicin—urinary bladder cancer	0.000634	0.000634	CcSEcCtD
Gemifloxacin—Skin disorder—Methotrexate—urinary bladder cancer	0.000631	0.000631	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.00063	0.00063	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000628	0.000628	CcSEcCtD
Gemifloxacin—Dry mouth—Epirubicin—urinary bladder cancer	0.00062	0.00062	CcSEcCtD
Gemifloxacin—Vertigo—Doxorubicin—urinary bladder cancer	0.000619	0.000619	CcSEcCtD
Gemifloxacin—Anorexia—Methotrexate—urinary bladder cancer	0.000619	0.000619	CcSEcCtD
Gemifloxacin—Syncope—Doxorubicin—urinary bladder cancer	0.000618	0.000618	CcSEcCtD
Gemifloxacin—Leukopenia—Doxorubicin—urinary bladder cancer	0.000617	0.000617	CcSEcCtD
Gemifloxacin—Palpitations—Doxorubicin—urinary bladder cancer	0.000609	0.000609	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000608	0.000608	CcSEcCtD
Gemifloxacin—Oedema—Epirubicin—urinary bladder cancer	0.000608	0.000608	CcSEcCtD
Gemifloxacin—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000606	0.000606	CcSEcCtD
Gemifloxacin—Shock—Epirubicin—urinary bladder cancer	0.000598	0.000598	CcSEcCtD
Gemifloxacin—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000596	0.000596	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000595	0.000595	CcSEcCtD
Gemifloxacin—Tachycardia—Epirubicin—urinary bladder cancer	0.000593	0.000593	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000592	0.000592	CcSEcCtD
Gemifloxacin—Skin disorder—Epirubicin—urinary bladder cancer	0.00059	0.00059	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000587	0.000587	CcSEcCtD
Gemifloxacin—Insomnia—Methotrexate—urinary bladder cancer	0.000587	0.000587	CcSEcCtD
Gemifloxacin—Myalgia—Doxorubicin—urinary bladder cancer	0.000587	0.000587	CcSEcCtD
Gemifloxacin—Arthralgia—Doxorubicin—urinary bladder cancer	0.000587	0.000587	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000582	0.000582	CcSEcCtD
Gemifloxacin—Anorexia—Epirubicin—urinary bladder cancer	0.000579	0.000579	CcSEcCtD
Gemifloxacin—Dyspnoea—Methotrexate—urinary bladder cancer	0.000579	0.000579	CcSEcCtD
Gemifloxacin—Somnolence—Methotrexate—urinary bladder cancer	0.000577	0.000577	CcSEcCtD
Gemifloxacin—Dry mouth—Doxorubicin—urinary bladder cancer	0.000574	0.000574	CcSEcCtD
Gemifloxacin—Dyspepsia—Methotrexate—urinary bladder cancer	0.000572	0.000572	CcSEcCtD
Gemifloxacin—Decreased appetite—Methotrexate—urinary bladder cancer	0.000564	0.000564	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000562	0.000562	CcSEcCtD
Gemifloxacin—Oedema—Doxorubicin—urinary bladder cancer	0.000562	0.000562	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000561	0.000561	CcSEcCtD
Gemifloxacin—Fatigue—Methotrexate—urinary bladder cancer	0.00056	0.00056	CcSEcCtD
Gemifloxacin—Pain—Methotrexate—urinary bladder cancer	0.000555	0.000555	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000554	0.000554	CcSEcCtD
Gemifloxacin—Shock—Doxorubicin—urinary bladder cancer	0.000553	0.000553	CcSEcCtD
Gemifloxacin—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000551	0.000551	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000551	0.000551	CcSEcCtD
Gemifloxacin—Insomnia—Epirubicin—urinary bladder cancer	0.00055	0.00055	CcSEcCtD
Gemifloxacin—Tachycardia—Doxorubicin—urinary bladder cancer	0.000549	0.000549	CcSEcCtD
Gemifloxacin—Skin disorder—Doxorubicin—urinary bladder cancer	0.000546	0.000546	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000544	0.000544	CcSEcCtD
Gemifloxacin—Dyspnoea—Epirubicin—urinary bladder cancer	0.000542	0.000542	CcSEcCtD
Gemifloxacin—Somnolence—Epirubicin—urinary bladder cancer	0.00054	0.00054	CcSEcCtD
Gemifloxacin—Anorexia—Doxorubicin—urinary bladder cancer	0.000536	0.000536	CcSEcCtD
Gemifloxacin—Dyspepsia—Epirubicin—urinary bladder cancer	0.000535	0.000535	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000531	0.000531	CcSEcCtD
Gemifloxacin—Decreased appetite—Epirubicin—urinary bladder cancer	0.000528	0.000528	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000525	0.000525	CcSEcCtD
Gemifloxacin—Fatigue—Epirubicin—urinary bladder cancer	0.000524	0.000524	CcSEcCtD
Gemifloxacin—Constipation—Epirubicin—urinary bladder cancer	0.00052	0.00052	CcSEcCtD
Gemifloxacin—Pain—Epirubicin—urinary bladder cancer	0.00052	0.00052	CcSEcCtD
Gemifloxacin—Urticaria—Methotrexate—urinary bladder cancer	0.000516	0.000516	CcSEcCtD
Gemifloxacin—Abdominal pain—Methotrexate—urinary bladder cancer	0.000513	0.000513	CcSEcCtD
Gemifloxacin—Body temperature increased—Methotrexate—urinary bladder cancer	0.000513	0.000513	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000512	0.000512	CcSEcCtD
Gemifloxacin—Insomnia—Doxorubicin—urinary bladder cancer	0.000509	0.000509	CcSEcCtD
Gemifloxacin—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000501	0.000501	CcSEcCtD
Gemifloxacin—Somnolence—Doxorubicin—urinary bladder cancer	0.0005	0.0005	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000497	0.000497	CcSEcCtD
Gemifloxacin—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000495	0.000495	CcSEcCtD
Gemifloxacin—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000489	0.000489	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000485	0.000485	CcSEcCtD
Gemifloxacin—Fatigue—Doxorubicin—urinary bladder cancer	0.000485	0.000485	CcSEcCtD
Gemifloxacin—Urticaria—Epirubicin—urinary bladder cancer	0.000483	0.000483	CcSEcCtD
Gemifloxacin—Pain—Doxorubicin—urinary bladder cancer	0.000481	0.000481	CcSEcCtD
Gemifloxacin—Constipation—Doxorubicin—urinary bladder cancer	0.000481	0.000481	CcSEcCtD
Gemifloxacin—Abdominal pain—Epirubicin—urinary bladder cancer	0.00048	0.00048	CcSEcCtD
Gemifloxacin—Body temperature increased—Epirubicin—urinary bladder cancer	0.00048	0.00048	CcSEcCtD
Gemifloxacin—Asthenia—Methotrexate—urinary bladder cancer	0.000466	0.000466	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.00046	0.00046	CcSEcCtD
Gemifloxacin—Pruritus—Methotrexate—urinary bladder cancer	0.000459	0.000459	CcSEcCtD
Gemifloxacin—Urticaria—Doxorubicin—urinary bladder cancer	0.000447	0.000447	CcSEcCtD
Gemifloxacin—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000444	0.000444	CcSEcCtD
Gemifloxacin—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000444	0.000444	CcSEcCtD
Gemifloxacin—Diarrhoea—Methotrexate—urinary bladder cancer	0.000444	0.000444	CcSEcCtD
Gemifloxacin—Asthenia—Epirubicin—urinary bladder cancer	0.000436	0.000436	CcSEcCtD
Gemifloxacin—Pruritus—Epirubicin—urinary bladder cancer	0.00043	0.00043	CcSEcCtD
Gemifloxacin—Dizziness—Methotrexate—urinary bladder cancer	0.000429	0.000429	CcSEcCtD
Gemifloxacin—Diarrhoea—Epirubicin—urinary bladder cancer	0.000416	0.000416	CcSEcCtD
Gemifloxacin—Vomiting—Methotrexate—urinary bladder cancer	0.000413	0.000413	CcSEcCtD
Gemifloxacin—Rash—Methotrexate—urinary bladder cancer	0.000409	0.000409	CcSEcCtD
Gemifloxacin—Dermatitis—Methotrexate—urinary bladder cancer	0.000409	0.000409	CcSEcCtD
Gemifloxacin—Headache—Methotrexate—urinary bladder cancer	0.000407	0.000407	CcSEcCtD
Gemifloxacin—Asthenia—Doxorubicin—urinary bladder cancer	0.000403	0.000403	CcSEcCtD
Gemifloxacin—Dizziness—Epirubicin—urinary bladder cancer	0.000402	0.000402	CcSEcCtD
Gemifloxacin—Pruritus—Doxorubicin—urinary bladder cancer	0.000398	0.000398	CcSEcCtD
Gemifloxacin—Vomiting—Epirubicin—urinary bladder cancer	0.000386	0.000386	CcSEcCtD
Gemifloxacin—Nausea—Methotrexate—urinary bladder cancer	0.000386	0.000386	CcSEcCtD
Gemifloxacin—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000385	0.000385	CcSEcCtD
Gemifloxacin—Rash—Epirubicin—urinary bladder cancer	0.000383	0.000383	CcSEcCtD
Gemifloxacin—Dermatitis—Epirubicin—urinary bladder cancer	0.000383	0.000383	CcSEcCtD
Gemifloxacin—Headache—Epirubicin—urinary bladder cancer	0.000381	0.000381	CcSEcCtD
Gemifloxacin—Dizziness—Doxorubicin—urinary bladder cancer	0.000372	0.000372	CcSEcCtD
Gemifloxacin—Nausea—Epirubicin—urinary bladder cancer	0.000361	0.000361	CcSEcCtD
Gemifloxacin—Vomiting—Doxorubicin—urinary bladder cancer	0.000358	0.000358	CcSEcCtD
Gemifloxacin—Rash—Doxorubicin—urinary bladder cancer	0.000355	0.000355	CcSEcCtD
Gemifloxacin—Dermatitis—Doxorubicin—urinary bladder cancer	0.000354	0.000354	CcSEcCtD
Gemifloxacin—Headache—Doxorubicin—urinary bladder cancer	0.000352	0.000352	CcSEcCtD
Gemifloxacin—Nausea—Doxorubicin—urinary bladder cancer	0.000334	0.000334	CcSEcCtD
